These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. van der Straten A, Moore J, Napierala S, Clouse K, Mauck C, Hammond N, Padian N. Contraception; 2008 Jun; 77(6):435-43. PubMed ID: 18477494 [Abstract] [Full Text] [Related]
31. Rectal microbicide acceptability: results of a volume escalation trial. Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Sex Transm Dis; 2007 Apr; 34(4):224-9. PubMed ID: 16906126 [Abstract] [Full Text] [Related]
32. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. Ramjee G, Morar NS, Braunstein S, Friedland B, Jones H, van de Wijgert J. AIDS Res Ther; 2007 Sep 27; 4():20. PubMed ID: 17900337 [Abstract] [Full Text] [Related]
33. Fourteen-day safety and acceptability study of the universal placebo gel. Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM. Contraception; 2007 Feb 27; 75(2):136-41. PubMed ID: 17241844 [Abstract] [Full Text] [Related]
34. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P. Lancet; 2008 Dec 06; 372(9654):1977-87. PubMed ID: 19059048 [Abstract] [Full Text] [Related]
37. Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa. van de Wijgert JH, Braunstein SL, Morar NS, Jones HE, Madurai L, Strickfaden TT, Moodley M, Aboobaker J, Ndlovu G, Ferguson TM, Friedland BA, Hart CE, Ramjee G. J Acquir Immune Defic Syndr; 2007 Dec 15; 46(5):538-46. PubMed ID: 18193495 [Abstract] [Full Text] [Related]
38. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents. Joanis CL, Hart CW. AIDS Behav; 2010 Jun 15; 14(3):600-6. PubMed ID: 20049522 [Abstract] [Full Text] [Related]
39. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction. Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L. J Int AIDS Soc; 2015 Jun 15; 18(1):20536. PubMed ID: 26700845 [Abstract] [Full Text] [Related]